Correlation Between HCW Biologics and TC BioPharm

Can any of the company-specific risk be diversified away by investing in both HCW Biologics and TC BioPharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and TC BioPharm into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between HCW Biologics and TC BioPharm plc, you can compare the effects of market volatilities on HCW Biologics and TC BioPharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of TC BioPharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and TC BioPharm.

Diversification Opportunities for HCW Biologics and TC BioPharm

0.09

Correlation Coefficient

HCW Biologics  TC BioPharm

Significant diversification

The 3 months correlation between HCW and TCBPW is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and TC BioPharm plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TC BioPharm plc and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with TC BioPharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TC BioPharm plc has no effect on the direction of HCW Biologics i.e., HCW Biologics and TC BioPharm go up and down completely randomly.

Pair Corralation between HCW Biologics and TC BioPharm

Given the investment horizon of 90 days HCW Biologics is expected to generate 28.15 times less return on investment than TC BioPharm. But when comparing it to its historical volatility, HCW Biologics is 4.67 times less risky than TC BioPharm. It trades about 0.02 of its potential returns per unit of risk. TC BioPharm plc is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  18.00  in TC BioPharm plc on October 6, 2024 and sell it today you would lose (16.80) from holding TC BioPharm plc or give up 93.33% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	87.16%
Values	Daily Returns

HCW Biologics  vs.  TC BioPharm plc

HCW Biologics

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in HCW Biologics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, HCW Biologics sustained solid returns over the last few months and may actually be approaching a breakup point.

TC BioPharm plc

Risk-Adjusted Performance

5 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in TC BioPharm plc are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, TC BioPharm showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with HCW Biologics and TC BioPharm

The main advantage of trading using opposite HCW Biologics and TC BioPharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, TC BioPharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TC BioPharm will offset losses from the drop in TC BioPharm's long position.

The idea behind HCW Biologics and TC BioPharm plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.